Compare PRG & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRG | TNDM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | PRG | TNDM |
|---|---|---|
| Price | $29.75 | $21.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 16 |
| Target Price | ★ $35.00 | $22.44 |
| AVG Volume (30 Days) | 477.8K | ★ 2.3M |
| Earning Date | 10-22-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 10.59 | N/A |
| EPS | ★ 3.96 | N/A |
| Revenue | ★ $2,507,179,000.00 | $1,007,001,000.00 |
| Revenue This Year | $1.32 | $8.59 |
| Revenue Next Year | $0.64 | $10.19 |
| P/E Ratio | $7.67 | ★ N/A |
| Revenue Growth | 3.71 | ★ 17.87 |
| 52 Week Low | $23.50 | $9.98 |
| 52 Week High | $48.77 | $38.28 |
| Indicator | PRG | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 66.05 |
| Support Level | $28.88 | $20.27 |
| Resistance Level | $31.52 | $22.10 |
| Average True Range (ATR) | 1.02 | 1.12 |
| MACD | 0.22 | -0.08 |
| Stochastic Oscillator | 56.21 | 91.59 |
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.